Skip to main content

Advertisement

Log in

RNA-dependent RNA polymerase (RdRp) natural antiviral inhibitors: a review

  • Review Article
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Viral diseases are the cause of many global epidemics, leading to deaths, affecting the quality of life of populations, and impairing public health. The limitations in the treatment of viral diseases and the constant resistance to conventional antiviral treatments encourage researchers to discover new compounds. In this perspective, this literature review presents isolated molecules and extracts of natural products capable of inhibiting the activity of the nonstructural protein that acts as the RNA-dependent RNA polymerase. The literature review presented natural compounds with the potential to be tested as alternative medicines or used in the development of synthetic drugs to prevent the replication of RNA viruses, such as COVID-19, hepatitis C, and dengue viruses, among others. Natural products are known to exhibit remarkable activities in mitigation of different viral diseases, in addition, they help to decrease the aggravation of infections. Consequently, reducing hospitalization time and deaths.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

Notes

  1. In fact, the inhibition of replication and transcription processes is a mechanism of action common to molecules capable of interfering with the activity of RdRp, present in RNA viruses. Flavonoids such as kaempterol, fisetin, hyperoside, afzelin, biorobin, myricitrin, astragalin, quercetin, quercetin-3-O-glycoside and quercitrin showed high affinity for RdRp using molecular docking.

Abbreviations

COVID-19 :

Coronavirus disease 2019

DAA :

Direct-acting antiviral

DENV :

Dengue

HCV :

Hepatitis C virus

HIV-1 :

Human immunodeficiency 1

MERS-CoV :

Middle East Respiratory Syndrome

NSPs :

Nonstructural proteins

PEG-IFN :

Pegylated interferon

RdRp :

RNA-dependent RNA polymerase

RdRp-DENV :

dengue virus RNA-dependent RNA polymerase

RdRp-HCV :

hepatitis C virus RNA-dependent RNA polymerase

SARS-CoV :

Severe Acute Respiratory Syndrome

WNV :

West Nile virus

References

  1. Christy MP, Uekusa Y, Gerwick L, Gerwick WH. Natural products with potential to treat RNA virus pathogens including SARS-CoV-2. J Nat Prod. 2021;84:161–82. https://doi.org/10.1021/acs.jnatprod.0c00968.

    Article  PubMed  CAS  Google Scholar 

  2. Zhu W, Chen CZ, Gorshkov K, Xu M, Lo DC, Zheng W. RNA-dependent RNA polymerase as a target for COVID-19 drug discovery. SLAS Discov. 2020;25:1141–51. https://doi.org/10.1177/2472555220942123.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Narayanan N, Nair DT. Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs. Int J Biol Macromol. 2021;168:272–8. https://doi.org/10.1016/j.ijbiomac.2020.12.038.

    Article  PubMed  CAS  Google Scholar 

  4. El-Tantawy WH, Temraz A. Natural products for the management of the hepatitis C virus: a biochemical review. Arch Physiol Biochem. 2020;126:116–28. https://doi.org/10.1080/13813455.2018.1498902.

    Article  PubMed  CAS  Google Scholar 

  5. Cosset FL, Mialon C, Boson B, Granier C, Denolly S. HCV interplay with lipoproteins: Inside or outside the cells. Viruses. 2020;12:434. https://doi.org/10.3390/v12040434.

    Article  PubMed Central  CAS  Google Scholar 

  6. Jo M, Nakamura N, Kakiuchi N, Komatsu K, Qui MH, Shimotohno K, et al. Inhibitory effect of Yunnan traditional medicines on hepatitis C viral polymerase. J Nat Med. 2006;60:217–24. https://doi.org/10.1007/s11418-006-0041-7.

    Article  PubMed  CAS  Google Scholar 

  7. Casey JL, Feld JJ, MacParland SA. Restoration of HCV-specific immune responses with antiviral therapy: a case for DAA treatment in acute HCV infection. Cells. 2019;8:317. https://doi.org/10.3390/cells8040317.

    Article  PubMed Central  CAS  Google Scholar 

  8. Coulerie P, Eydoux C, Hnawia E, Stuhl L, MacIuk A, Lebouvier N, et al. Biflavonoids of Dacrydium balansae with potent inhibitory activity on dengue 2 NS5 polymerase. Planta Med. 2012;78:672–7. https://doi.org/10.1055/s-0031-1298355.

    Article  PubMed  CAS  Google Scholar 

  9. Cannalire R, Ki Chan KW, Burali MS, Gwee CP, Wang S, Astolfi A, et al. Pyridobenzothiazolones exert potent anti-dengue activity by hampering multiple functions of NS5 polymerase. ACS Med Chem Lett. 2020;11:773–82. https://doi.org/10.1021/acsmedchemlett.9b00619.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Artika IM, Wiyatno A, Ma’roef CN. Pathogenic viruses: molecular detection and characterization. Infect Genet Evol. 2020;81:104215. https://doi.org/10.1016/j.meegid.2020.104215.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–23. https://doi.org/10.1002/jmv.25681.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. COVID-19 Map—Johns Hopkins Coronavirus Resource Center. 2021. Im Internet. https://coronavirus.jhu.edu/map.html.

  13. WHO | World Health Organization. 2021. Im Internet: https://www.who.int/.

  14. Sedeño-Monge V, Laguna-Meraz S, Santos-López G, Panduro A, Sosa-Jurado F, Jose-Abrego A, et al. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico-a systematic review and meta-analysis (2008–2019). Ann Hepatol. 2021;20:100292. https://doi.org/10.1016/j.aohep.2020.100292.

    Article  PubMed  Google Scholar 

  15. Peyrat LA, Eparvier V, Eydoux C, Guillemot JC, Litaudon M, Stien D. Betulinic acid, the first Lupane-type triterpenoid isolated from both a Phomopsis sp. and Its host plant diospyros carbonaria Benoist. Chem Biodivers. 2017;14:e1600171. https://doi.org/10.1002/cbdv.201600171.

    Article  CAS  Google Scholar 

  16. Tseliou M, Pirintsos SA, Lionis C, Castanas E, Sourvinos G. Antiviral effect of an essential oil combination derived from three aromatic plants (Coridothymus capitatus (L.) Rchb. f., Origanum dictamnus L. and Salvia fruticosa Mill.) against viruses causing infections of the upper respiratory tract. J Herb Med. 2019;17–18:100288. https://doi.org/10.1016/j.hermed.2019.100288.

    Article  Google Scholar 

  17. Tahir ul Qamar M, Alqahtani SM, Alamri MA, Chen LL. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10:313–9. https://doi.org/10.1016/j.jpha.2020.03.009.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Manvar D, Mishra M, Kumar S, Pandey VN. Identification and evaluation of anti Hepatitis C virus phytochemicals from Eclipta alba. J Ethnopharmacol. 2012;144:545–54. https://doi.org/10.1016/j.jep.2012.09.036.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Ramalingam S, Karupannan S, Padmanaban P, Vijayan S, Sheriff K, Palani G, et al. Anti-dengue activity of Andrographis paniculata extracts and quantification of dengue viral inhibition by SYBR green reverse transcription polymerase chain reaction. AYU. 2018;39:87. https://doi.org/10.4103/ayu.ayu_144_17.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ravikumar YS, Ray U, Nandhitha M, Perween A, Raja Naika H, Khanna N, et al. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus Res. 2011;158:89–97. https://doi.org/10.1016/j.virusres.2011.03.014.

    Article  PubMed  CAS  Google Scholar 

  21. Allard PM, Dau ETH, Eydoux C, Guillemot JC, Dumontet V, Poullain C, et al. Alkylated flavanones from the bark of cryptocarya chartacea as dengue virus NS5 polymerase inhibitors. J Nat Prod. 2011;74:2446–53. https://doi.org/10.1021/np200715v.

    Article  PubMed  CAS  Google Scholar 

  22. Peyrat LA, Eparvier V, Eydoux C, Guillemot JC, Litaudon M, Stien D. Carneic Acids from an Endophytic Phomopsis sp. as Dengue Virus Polymerase Inhibitors. J Nat Prod. 2020;83:2330–6. https://doi.org/10.1021/acs.jnatprod.9b01169.

    Article  PubMed  CAS  Google Scholar 

  23. Zhu MM, Wang L, Yang D, Li C, Pang S-T, Li X-H, et al. Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway. Biomed Pharmacother. 2019;117:109088. https://doi.org/10.1016/j.biopha.2019.109088.

    Article  PubMed  CAS  Google Scholar 

  24. Pan H, Lin Y, Dou J, Fu Z, Yao Y, Ye S, et al. Wedelolactone facilitates Ser/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis. Cell Prolif. 2020;53:e12868. https://doi.org/10.1111/cpr.12868.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Rong S, Wan D, Fan Y, Liu S, Sun K, Huo J, et al. Amentoflavone affects epileptogenesis and exerts neuroprotective effects by inhibiting NLRP3 inflammasome. Front Pharm. 2019;10:856. https://doi.org/10.3389/fphar.2019.00856.

    Article  CAS  Google Scholar 

  26. Zhao Q, Li HM, Chen XQ, Li RT, Liu D. Terpenoids from Tripterygium hypoglaucum and Their Anti-Inflammatory Activity. Chem Nat Compd. 2018;54:471–4. https://doi.org/10.1007/s10600-018-2381-4.

    Article  CAS  Google Scholar 

  27. Mouffouk C, Mouffouk S, Mouffouk S, Hambaba L, Haba H. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2). Eur J Pharmacol. 2021;891:173759. https://doi.org/10.1016/j.ejphar.2020.173759.

    Article  PubMed  CAS  Google Scholar 

  28. Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L. et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2021;26:1044–59. https://doi.org/10.1038/s41380-020-00965-3.

    Article  PubMed  CAS  Google Scholar 

  29. Zahedipour F, Hosseini SA, Sathyapalan T, Majeed M, Jamialahmadi T, Al-Rasadi K. et al. Potential effects of curcumin in the treatment of COVID-19 infection. Phyther Res. 2020;34:2911–20. https://doi.org/10.1002/ptr.6738.

    Article  CAS  Google Scholar 

  30. Kong L, Li S, Liao Q, Zhang Y, Sun R, Zhu X, et al. Oleanolic acid and ursolic acid: Novel hepatitis C virus antivirals that inhibit NS5B activity. Antivir Res. 2013;98:44–53. https://doi.org/10.1016/j.antiviral.2013.02.003.

    Article  PubMed  CAS  Google Scholar 

  31. Peyrat LA, Eparvier V, Eydoux C, Guillemot JC, Stien D, Litaudon M. Chemical diversity and antiviral potential in the pantropical Diospyros genus. Fitoterapia. 2016;112:9–15. https://doi.org/10.1016/j.fitote.2016.04.017.

    Article  PubMed  CAS  Google Scholar 

  32. Goh VSL, Mok CK, Chu JJH. Antiviral natural products for arbovirus infections. Molecules. 2020;25:2796. https://doi.org/10.3390/molecules25122796.

    Article  PubMed Central  CAS  Google Scholar 

  33. Reddy BU, Mullick R, Kumar A, Sharma G, Bag P, Roy CL. et al. A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage. Antivir Res. 2018;150:47–59. https://doi.org/10.1016/j.antiviral.2017.12.004.

    Article  PubMed  CAS  Google Scholar 

  34. Kim JW, Park SJ, Lim JH, Yang JW, Shin JC, Lee SW, et al. Triterpenoid saponins isolated from Platycodon grandiflorum inhibit Hepatitis C virus replication. Evid Based Complement Altern Med. 2013;2013. https://doi.org/10.1155/2013/560417.

  35. Bekut M, Brkić S, Kladar N, Dragović G, Gavarić N, Božin B. Potential of selected Lamiaceae plants in anti(retro) viraltherapy. Pharm Res. 2018;133:301–14. https://doi.org/10.1016/j.phrs.2017.12.016.

    Article  Google Scholar 

  36. Ito T, Yokota R, Watarai T, Mori K, Oyama M, Nagasawa H, et al. Isolation of six isoprenylated biflavonoids from the leaves of Garcinia subelliptica. Chem Pharm Bull. 2013;61:551–8. https://doi.org/10.1248/cpb.c12-01057.

    Article  CAS  Google Scholar 

  37. Tsalikis J, Abdel-Nour M, Farahvash A, Sorbara MT, Poon S, Philpott DJ, et al. Isoginkgetin, a Natural Biflavonoid Proteasome Inhibitor, Sensitizes Cancer Cells to Apoptosis via Disruption of Lysosomal Homeostasis and Impaired Protein Clearance. Mol Cell Biol. 2019;39. https://doi.org/10.1128/mcb.00489-18.

  38. Pawellek A, Ryder U, Tammsalu T, King LJ, Kreinin H, Ly T, et al. Characterisation of the biflavonoid hinokiflavone as a pre-mrna splicing modulator that inhibits senp. Elife. 2017;6. https://doi.org/10.7554/eLife.27402.

  39. Salvador JAR, Leal AS, Valdeira AS, Gonçalves BMF, Alho DPS, Figueiredo SAC, et al. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: recent advances in cancer treatment. Eur J Med Chem. 2017;142:95–130. https://doi.org/10.1016/j.ejmech.2017.07.013.

    Article  PubMed  CAS  Google Scholar 

  40. Ríos JL, Máñez S. New pharmacological opportunities for betulinic acid. Planta Med. 2018;84:8–19. https://doi.org/10.1055/s-0043-123472.

    Article  PubMed  CAS  Google Scholar 

  41. Guenné S, Ouattara N, Ouédraogo N, Ciobica A, Hilou A, Kiendrebeógo M. Phytochemistry and neuroprotective effects of Eclipta alba (L.) Hassk. J Complement Integr Med. 2020;17. https://doi.org/10.1515/jcim-2019-0026.

  42. Patel JR, Tripathi P, Sharma V, Chauhan NS, Dixit VK. Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review. J Ethnopharmacol. 2011;138:286–313. https://doi.org/10.1016/j.jep.2011.09.040.

    Article  PubMed  CAS  Google Scholar 

  43. Liu C, Pan J, Wang A, Lan Y, Li Y, Lu Y. et al. Efficacy of water fraction from Dioscorea cirrhosa on oxidative stress and apoptosis in H9c2 cardiomyocytes induced by H2O2. J Tradit Chin Med. 2021;41:51–8. https://doi.org/10.19852/j.cnki.jtcm.2021.01.007.

    Article  PubMed  Google Scholar 

  44. Iddir M, Brito A, Dingeo G, Del Campo SSF, Samouda H, La Frano MR, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the covid-19 crisis. Nutrients. 2020;12:1562. https://doi.org/10.3390/nu12061562.

    Article  PubMed Central  CAS  Google Scholar 

  45. Pratheeba T, Taranath V, Sai Gopal DVR, Natarajan D. Antidengue potential of leaf extracts of Pavetta tomentosa and Tarenna asiatica (Rubiaceae) against dengue virus and its vector Aedes aegypti (Diptera: Culicidae). Heliyon. 2019;5. https://doi.org/10.1016/j.heliyon.2019.e02732.

  46. Miladi S, Abid N, Debarnôt C, Damak M, Canard B, Aouni M, et al. In vitro antiviral activities of extracts derived from Daucus maritimus seeds. Nat Prod Res. 2012;26:1027–32. https://doi.org/10.1080/14786419.2010.550263.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Ensino Superior, Brazil)—Funding code 001 and CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil). The authors would like to thank the Academic Publishing Advisory Center (Centro de Assessoria de Publicação Acadêmica, CAPA—www.capa.ufpr.br) of the Federal University of Paraná (UFPR) for assistance with English language translation and developmental editing. Thanks to Center National de la recherché Scientifique (CNRS-France) and to the University of Poitiers-France for support.

Author contributions

DRBL: Conceptualization, methodology, research, writing-original draft, writing-revision and editing, visualization, project administration, acquisition of financing. SPC: Research, original draft writing, acquisition of funding. KMM: Software, resources, data curation, acquisition of funding. FCMB: Formal analysis, acquisition of financing. EdBS: Formal analysis, acquisition of financing. FBM: Software, visualization, acquisition of financing. DPM: Conceptualization, acquisition of financing. JdFGD: Conceptualization, acquisition of financing. OGM: Conceptualization, acquisition of financing. MDM: Conceptualization, supervision, acquisition of financing.

Funding

DRBL, SPC, FBM, FCMB, and EdBS received funding from CAPES (Coordenação de Aperfeiçoamento de Pessoal de Ensino Superior, Brazil), KMM received funding from Center National de la recherche Scientifique (CNRS-France), DPM and JdFGD received funding from Universidade Federal do Paraná (UFPR), CAPES (Coordenação de Aperfeiçoamento de Pessoal de Ensino Superior, Brazil) and OGM and MDM received funding from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Universidade Federal do Paraná (UFPR).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniela Regina Buch Leite.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leite, D.R.B., Mantovani, K.M., Cordeiro, S.P. et al. RNA-dependent RNA polymerase (RdRp) natural antiviral inhibitors: a review. Med Chem Res 31, 2089–2102 (2022). https://doi.org/10.1007/s00044-022-02963-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-022-02963-2

Keywords